Signal transduction mechanisms in human eosinophils.
Shute
J
J
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000494:pharmacology; D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D003994:Bucladesine / Q000494:pharmacology; D020013:Calcium Signaling / Q000187:drug effects; D002454:Cell Differentiation; D002478:Cells, Cultured; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D000242:Cyclic AMP / Q000502:physiology; D016207:Cytokines / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D047091:Eosinophil Granule Proteins; D047209:Eosinophil Peroxidase; D047208:Eosinophil-Derived Neurotoxin; D004804:Eosinophils / Q000276:immunology / Q000502:physiology*; D006168:Guinea Pigs; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000097:blood / Q000473:pathology; D015472:Leukemia, Eosinophilic, Acute / Q000473:pathology; D008253:Macaca mulatta; D010544:Peroxidases / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D010972:Platelet Activating Factor / Q000494:pharmacology; D011493:Protein Kinase C / Q000502:physiology; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D011506:Proteins / Q000378:metabolism; D018121:Receptors, Cytokine / Q000187:drug effects / Q000502:physiology; D011961:Receptors, Fc / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology; D012260:Ribonucleases; D015398:Signal Transduction; D014407:Tumor Cells, Cultured
D001798:Blood Proteins; D016207:Cytokines; D004791:Enzyme Inhibitors; D047091:Eosinophil Granule Proteins; D010972:Platelet Activating Factor; D011506:Proteins; D018121:Receptors, Cytokine; D011961:Receptors, Fc; D003994:Bucladesine; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D000242:Cyclic AMP; D047209:Eosinophil Peroxidase; D010544:Peroxidases; D011493:Protein Kinase C; D047208:Eosinophil-Derived Neurotoxin; D012260:Ribonucleases